Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 263.95M USD
- Enterprise value
- 73.97M USD
- Trailing P/E
- —
- Forward P/E
- -4.69
- Price / sales
- —
- Price / book
- 1.88
- EV / EBITDA
- -0.86
- Beta
- 0.78
- Dividend yield
- —
- Profit margin
- 0.00%
- Return on equity
- -44.98%
- Debt / equity
- —
- Earnings growth
- —
- Revenue growth
- —
- Free cash flow
- -43.61M USD
- Operating cash flow
- -69.35M USD
- Shares outstanding
- 57.01M
- Sector
- Healthcare
- Industry
- Biotechnology
Updated Sep 2, 2026, 4:02 AM